-+ 0.00%
-+ 0.00%
-+ 0.00%

Crescent Biopharma shareholders elect two Class II directors at annual meeting

PUBT·06/03/2026 13:03:31
Listen to the news
Crescent Biopharma shareholders elect two Class II directors at annual meeting
  • Crescent Biopharma held its annual general meeting on June 2, 2026.
  • Shareholders ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
  • Shareholders backed an annual schedule for future advisory votes on executive pay; the board set the vote to occur every year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crescent Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-040051), on June 03, 2026, and is solely responsible for the information contained therein.